Axa
GWPH

Axa’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Axa’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-49,687
Closed -$6.1M – 1383
2020
Q2 		$6.1M Buy
49,687
+2,481
+5% +$281K 0.02% 553
2020
Q1 		$4.13M Sell
47,206
-3,520
-7% -$373K 0.02% 571
2019
Q4 		$5.3M Buy
50,726
+1,203
+2% +$135K 0.02% 602
2019
Q3 		$5.7M Sell
49,523
-81
-0.2% -$12.3K 0.02% 607
2019
Q2 		$8.55M Buy
49,604
+960
+2% +$166K 0.03% 512
2019
Q1 		$8.2M Hold
48,644
– – 0.03% 508
2018
Q4 		$4.74M Hold
48,644
– – 0.02% 618
2018
Q3 		$8.4M Sell
48,644
-10,662
-18% -$1.54M 0.03% 523
2018
Q2 		$8.28M Sell
59,306
-33,943
-36% -$4.82M 0.03% 510
2018
Q1 		$10.5M Sell
93,249
-944
-1% -$119K 0.04% 427
2017
Q4 		$12.4M Sell
94,193
-98
-0.1% -$11.5K 0.05% 397
2017
Q3 		$9.57M Buy
+94,291
New +$10.1M 0.04% 448

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Axa's GWPH Position: Q3 2020 in Review

Axa sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 49,687 shares — an estimated $6.1M sold.

Axa first reported a position in GWPH in Q3 2017 and held it in 12 quarters. The position peaked at $12.4M in Q4 2017. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • Axa reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Axa sold 49,687 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $6.1M.
  • Axa first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 12 quarters.
  • Axa's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.4M in Q4 2017.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Axa's 13F filing for Q3 2020, filed 13 Nov 2020.